Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
Dulaglutide reduces HbA(1c) irrespective of...
Conference

Dulaglutide reduces HbA(1c) irrespective of antihyperglycaemic agents, duration of diabetes, BMI and weight loss: a post hoc analysis from the REWIND trial

Authors

Xavier D; Kwan A; Gerstein H; Basile J; Maldonado JM; Raha S; Konig M

Volume

63

Pagination

pp. S288-S288

Publisher

SPRINGER

Publication Date

September 1, 2020

Name of conference

56th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)

Conference place

ELECTR NETWORK

Conference start date

September 21, 2020

Conference end date

September 25, 2020

Conference proceedings

DIABETOLOGIA

Issue

SUPPL 1

ISSN

0012-186X

Labels